BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8976914)

  • 1. Should women with implants or a history of treatment for breast cancer be excluded from mammography screening programs?
    Kopans DB; Moore RH; McCarthy KA; Hall DA; Hulka CA; Whitman GJ; Slanetz PJ; Halpern EF
    AJR Am J Roentgenol; 1997 Jan; 168(1):29-31. PubMed ID: 8976914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening mammography: value in women 35-39 years old.
    Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
    AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with imaging and procedural events used to detect breast cancer after screening mammography.
    Carney PA; Abraham LA; Miglioretti DL; Yabroff KR; Sickles EA; Buist DS; Kasales CJ; Geller BM; Rosenberg RD; Dignan MB; Weaver DL; Kerlikowske K;
    AJR Am J Roentgenol; 2007 Feb; 188(2):385-92. PubMed ID: 17242246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome analysis for women undergoing annual versus biennial screening mammography: a review of 24,211 examinations.
    Hunt KA; Rosen EL; Sickles EA
    AJR Am J Roentgenol; 1999 Aug; 173(2):285-9. PubMed ID: 10430120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a mailed intervention on annual mammography and physician breast examinations among women at high risk of breast cancer.
    Richardson JL; Mondrus GT; Danley K; Deapen D; Mack T
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):71-6. PubMed ID: 8770470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening mammography for women in their 40s: a retrospective study of the potential impact of the U.S. Preventive Service Task Force's 2009 breast cancer screening recommendations.
    Arleo EK; Dashevsky BZ; Reichman M; Babagbemi K; Drotman M; Rosenblatt R
    AJR Am J Roentgenol; 2013 Dec; 201(6):1401-6. PubMed ID: 24261383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and characteristics of additionally detected ipsilateral breast lesions following recall at screening mammography.
    Lameijer JR; Coolen AM; Nederend J; Voogd AC; Tjan-Heijnen VC; Duijm LE
    Breast; 2018 Dec; 42():94-101. PubMed ID: 30216838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan.
    Tohno E; Umemoto T; Sasaki K; Morishima I; Ueno E
    Eur J Radiol; 2013 Aug; 82(8):1227-30. PubMed ID: 23465737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of mammographic screening relative to the treatment of women with carcinoma of the breast.
    Solin LJ; Legorreta A; Schultz DJ; Zatz S; Goodman RL
    Arch Intern Med; 1994 Apr; 154(7):745-52. PubMed ID: 8147678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of interval breast cancer rates for two-versus single-view screening mammography: a population-based study.
    Seigneurin A; Exbrayat C; Labarère J; Colonna M
    Breast; 2009 Oct; 18(5):284-8. PubMed ID: 19713113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient burden of screening mammography recall.
    Alcusky M; Philpotts L; Bonafede M; Clarke J; Skoufalos A
    J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S11-9. PubMed ID: 25247382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series.
    Paszat L; Sutradhar R; Grunfeld E; Gainford C; Benk V; Bondy S; Coyle D; Holloway C; Sawka C; Shumak R; Vallis K; van Walraven C
    Breast Cancer Res Treat; 2009 Mar; 114(1):169-78. PubMed ID: 18368477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.